Нутритивная поддержка первичных больных раком пищевода (аналитический обзор)

1. Обухова О.А. Стратегия питательной поддержки при проведении противоопухолевого лечения. РМЖ. 2009;17(22):1500-4 [Obukhova OA. Nutritional support strategy during anticancer treatment. RMJ. 2009;17(22):1500-4 (in Russian)]. 
2. Wu J, Huang C, Xiao H, et al. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition. 2013;29(11‑12):1310‑4. DOI:10.1016/j.nut.2013.04.010
3. Hellstadius Y, Lagergren J, Zylstra J, et al. Prevalence and predictors of anxiety and depression among esophageal cancer patients prior to surgery. Dis Esophagus.
2016;29(8):1128-34. DOI:10.1111/dote.12437
4. Hébuterne X, Lemarié E, Michallet M, et al. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN. 2014;38(2):196‑204. DOI:10.1177/0148607113502674
5. Laviano A, Di Lazzaro L, Koverech A. Nutrition support and clinical outcome in advanced cancer patients. Proc Nutr Soc. 2018;77(4):388-93. DOI:10.1017/S0029665118000459
6. Обухова О.А., Курмуков И.А., Рык А.А. Влияние нутритивной поддержки на питательный статус, качество жизни и выживаемость у онкологических больных, получающих системное лекарственное противоопухолевое лечение. Клиническое питание и метаболизм. 2022;3(1):50-61 [Obukhova OA, Kurmukov IA, Ryk AA. Impact of nutritional support on nutritional status, quality of life and survival in cancer patients receiving systemic anticancer drug treatment. Clinical Nutrition and Metabolism. 2022;3(1):50-61 (in Russian)]. DOI:10.17816/clinutr104771
7. Soma D, Kawamura YI, Yamashita S, et al. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. Dis Esophagus. 2019;32(3):doy092. DOI:10.1093/dote/doy092
8. Mitzman B, Schipper PH, Edwards MA, et al. Complications After Esophagectomy Are Associated With Extremes of Body Mass Index. Ann Thorac Surg. 2018;106(4):973-80. DOI:10.1016/j.athoracsur.2018.05.056
9. Papaconstantinou D, Vretakakou K, Paspala A, et al. The impact of preoperative sarcopenia on postoperative complications following esophagectomy for esophageal neoplasia: a systematic review and meta-analysis. Dis Esophagus. 2020;20:doaa002. DOI:10.1093/dote/doaa002
10. Anandavadivelan P, Brismar TB, Nilsson M, et al. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr. 2016;35(3):724-30. DOI:10.1016/j.clnu.2015.05.011
11. Tan BHL, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol. 2015;41(3):333-8. DOI:10.1016/j.ejso.2014.11.040
12. Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol. 2020;54(2):237-46. DOI:10.2478/raon-2020-0016
13. Лядов В.К., Дикова Т.С., Зацепина А.Ю., Иващенко Д.В. Миостеатоз и его влияние на результаты лечения больных с опухолями желудочно-кишечного тракта: систематический обзор и метаанализ. Современная Онкология. 2022;24(2):234-41 [Lyadov VK, Dikova TS, Zatsepina AYu, Ivashchenko DV. Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: sistematic review. Journal of Modern Oncology. 2022;24(2):234-41 (in Russian)]. DOI:10.26442/18151434.2022.2.201710
14. Qian J, Si Y, Zhou K, et al. Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy. BMC Gastroenterol. 2022;22(1):211. DOI:10.1186/s12876-022-02296-9
15. Иванова А.С., Обухова О.А., Курмуков И.А., Вольф Л.Я. Обзор практических рекомендаций ESPEN-2021 для онкологических больных. Часть 1. Клиническое питание и метаболизм. 2022;3(3):140-52 [Ivanova AS, Obukhova OA, Kurmukov IA, Volf LY. Review of ESPEN-2021 Practice Guidelines for Cancer Patients: Part 1. Clinical Nutrition and Metabolism. 2022;3(3):140-52 (in Russian)]. DOI:10.17816/clinutr111900
16. Cederholm T, Jensen G, Correia MI, et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10(1):207-17. DOI:10.1002/jcsm.12383
17. Hersberger L, Bargetzi L, Bargetzi A, et al. Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short-term and long-term clinical outcomes: secondary analysis of a prospective randomised trial. Clin Nutr. 2020;39(9):2720-9. DOI:10.1016/j.clnu.2019.11.041
18. Сытов А.В., Зузов С.А., Кукош М.Ю., и др. Практические рекомендации по нутритивной поддержке онкологических больных. Злокачественные опухоли.
2022;12(3S2-2):123-33 [Sytov AV, Zuzov SA, Kukosh MYu, et al. Practical recommendations for nutritional support of cancer patients. Malignant Tumors. 2022;12(3S2-2):123-33 (in Russian)]. DOI:10.18027/2224-5057-2022-12-3s2-123-133
19. Kemper M, Molwitz I, Krause L, et al. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer? Clin Nutr. 2021;40(6):3729-40. DOI:10.1016/j.clnu.2021.04.040
20. Barcellos PS, Borges N, Torres DPM. Resting energy expenditure in cancer patients: Agreement between predictive equations and indirect calorimetry. Clin Nutr ESPEN.
2021;42:286-91. DOI:10.1016/j.clnesp.2021.01.019
21. Souza MTP, Singer P, Ozorio GA, et al. Resting energy expenditure and body composition in patients with head and neck cancer: An observational study leading to a new predictive equation. Nutrition. 2018;51-52:60-5. DOI:10.1016/j.nut.2017.12.006
22. Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021:40(5):2898-913. DOI:10.1016/j.clnu.2021.02.005
23. Cao DX, Wu GH, Zhang B, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr. 2010;29(1):72-7. 
DOI:10.1016/j.clnu.2009.07.001
24. Movahed S, Norouzy A, Ghanbari-Motlagh A, et al. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev. 2020;21(8):2315-23. DOI:10.31557/APJCP.2020.21.8.2315
25. Pham Van B, Nguyen Thi Thanh H, Le Thi H, et al. Nutritional Status and Feeding Regimen of Patients with Esophagus Cancer – A Study from Vietnam. Healthcare (Basel). 2021;9(3):289. DOI:10.3390/healthcare9030289
26. Cao Y, Han D, Zhou X, et al. Effects of preoperative nutrition on postoperative outcomes in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2022;35(3):doab028. DOI:10.1093/dote/doab028
27. Ravasco P, Monteiro Grillo I, Marques Vidal P, Camilo M. Nutritional counselling vs supplements: A prospective randomised controlled trial in head-neck cancer patients undergoing radiotherapy. Clin Nutr. 2003;22(Suppl. 1):S63-4. DOI:10.1016/s0261-5614(03)80236-4 
28. Обухова О.А., Багрова С.Г., Бесова Н.С., и др. Влияние дополнительного энтерального питания с высоким содержанием белка и ω-3 жирных кислот на пищевой статус и функциональное состояние при проведении химиотерапии у больных раком желудка. Вопросы питания. 2018;87(S5):106-7 [Obukhova OA, Bagrova SG, Besova NS, et al. The influence of additional enteral nutrition with a high content of protein and ω-3 fatty acids on the nutritional status and functional state during chemotherapy in patients with gastric cancer. Nutrition Issues. 2018;87(S5):106-7 (in Russian)]. DOI:10.24411/0042-8833-2018-10200 
29. Martin L, Findlay M, Bauer JD, et al. A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer: Results from INFORM. Nutrients. 2022;14(24):5272. DOI:10.3390/nu14245272
30. De Haan JJ, Moshage Y, Renken RJ, et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer. 2021;29(10):5691-9. DOI:10.1007/s00520-021-06049-4
31. Спиридонов В.К., Толочко З.С. Капсаицин-чувствительные нервы и окислительный стресс. Бюллетень Сибирского отделения Российской академии медицинских наук. 2010;30(4):76-81 [Spiridonov VK, Tolochko ZS. Capsacin-sensory nerves and oxidative stress. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 2010;30(4):76-81 (in Russian)]. 
32. Liu B, Fan L, Balakrishna S, et al. TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain. 2013;154(10):2169-77. DOI:10.1016/j.pain.2013.06.043
33. Обухова О.А., Кашия Ш.Р., Курмуков И.А., и др. Применение дополнительного орального питания при проведении противоопухолевой химиотерапии. Проспективное рандомизированное контролируемое исследование. Вестник интенсивной терапии. 2009;3:47-52 [Obukhova OA, Kashiya ShR, Kurmukov IA, et al. The use of additional oral nutrition during anticancer chemotherapy. A prospective randomized controlled trial. Intensive Care Bulletin. 2009;3:47-52 (in Russian)]. 
34. Kubota K, Kuroda J, Yoshida M, et al. Preoperative oral supplementation support in patients with esophageal cancer. J Nutr Health Aging. 2014;18(4):437-40.
DOI:10.1007/s12603-014-0018-2
35. Shen Y, Zhou Y, He T, Zhuang X. Effect of preoperative nutritional risk screening and enteral nutrition support in accelerated recovery after resection for esophageal cancer. Nutr Cancer. 2021;73(4):596-601. DOI:10.1080/01635581.2020.1764981
36. Faber J, Uitdehaag MJ, Spaander M, et al. Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. J Cachexia Sarcopenia Muscle. 2015;6(1):32-44. DOI:10.1002/jcsm.12009
37. Low DE, Allum W, De Manzoni G, et al. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations. World J Surg. 2019;43(2):299-330. DOI:10.1007/s00268-018-4786-4 
38. Обухова О.А., Кашия Ш.Р., Курмуков И.А., Салтанов И.А. Гипергликемия критических состояний. Медицина невідкладних станів. 2011;4(35) [Obukhova OA, Kashiya ShR, Kurmukov IA, Saltanov IA. Hyperglycemia of critical conditions. Emergency Medicine. 2011;4(35) (in Russian)].
39. Liao M, Xia Z, Huang P, et al. Early enteral feeding on esophageal cancer patients after esophageal resection and reconstruction. Ann Palliat Med. 2020;9(3):816‑23. DOI:10.21037/apm.2020.04.13
40. Иванова А.С., Обухова О.А., Курмуков И.А., Вольф Л.Я. Обзор практических рекомендаций ESPEN-2021 для онкологических больных. Часть 2: частные вопросы нутритивной поддержки. Клиническое питание и метаболизм. 2022;3(4):193-206 [Ivanova AS, Obukhova OA, Kurmukov IA, VolfLYa. Review of ESPEN-2021 Practice Guidelines for Patients with Cancer. Part 2: Interventions Relevant to Specific Patient Categories. Clinical Nutrition and Metabolism. 2022;3(4):193-206 (in Russian)]. DOI:10.17816/clinutr119059
41. Deftereos I, Yeung JMC, Arslan J, et al. Adherence to ESPEN guidelines and associations with postoperative outcomes in upper gastrointestinal cancer resection: results from the multi-centre NOURISH point prevalence study. Clin Nut ESPEN. 2021;47:391-8. DOI:10.1016/j.clnesp.2021.10.019
42. Constansia RDN, Hentzen JEKR, Hogenbirk RNM, et al. Actual postoperative protein and calorie intake in patients undergoing major open abdominal cancer surgery: A prospective, observational cohort study. Nutr Clin Pract. 2022;37(1):183-91. DOI:10.1002/ncp.10678
43. Papier I, Sagi-Dain L, Chermesh I, et al. Absence of oral nutritional support in low food intake inpatients is associated with an increased risk of hospital-acquired pressure injury. Clin Nutr ESPEN. 2022;51:190-8. DOI:10.1016/j.clnesp.2022.09.003
44. Liu L, Wang YC, Liu QW, et al. Home enteral nutrition after esophagectomy for esophageal cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(36):e21988. DOI:10.1097/MD.0000000000021988

________________________________________________

1. Obukhova OA. Nutritional support strategy during anticancer treatment. RMJ. 2009;17(22):1500-4 (in Russian). 
2. Wu J, Huang C, Xiao H, et al. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition. 2013;29(11‑12):1310‑4. DOI:10.1016/j.nut.2013.04.010
3. Hellstadius Y, Lagergren J, Zylstra J, et al. Prevalence and predictors of anxiety and depression among esophageal cancer patients prior to surgery. Dis Esophagus.
2016;29(8):1128-34. DOI:10.1111/dote.12437
4. Hébuterne X, Lemarié E, Michallet M, et al. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN. 2014;38(2):196‑204. DOI:10.1177/0148607113502674
5. Laviano A, Di Lazzaro L, Koverech A. Nutrition support and clinical outcome in advanced cancer patients. Proc Nutr Soc. 2018;77(4):388-93. DOI:10.1017/S0029665118000459
6. Obukhova OA, Kurmukov IA, Ryk AA. Impact of nutritional support on nutritional status, quality of life and survival in cancer patients receiving systemic anticancer drug treatment. Clinical Nutrition and Metabolism. 2022;3(1):50-61 (in Russian). DOI:10.17816/clinutr104771
7. Soma D, Kawamura YI, Yamashita S, et al. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. Dis Esophagus. 2019;32(3):doy092. DOI:10.1093/dote/doy092
8. Mitzman B, Schipper PH, Edwards MA, et al. Complications After Esophagectomy Are Associated With Extremes of Body Mass Index. Ann Thorac Surg. 2018;106(4):973-80. DOI:10.1016/j.athoracsur.2018.05.056
9. Papaconstantinou D, Vretakakou K, Paspala A, et al. The impact of preoperative sarcopenia on postoperative complications following esophagectomy for esophageal neoplasia: a systematic review and meta-analysis. Dis Esophagus. 2020;20:doaa002. DOI:10.1093/dote/doaa002
10. Anandavadivelan P, Brismar TB, Nilsson M, et al. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr. 2016;35(3):724-30. DOI:10.1016/j.clnu.2015.05.011
11. Tan BHL, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol. 2015;41(3):333-8. DOI:10.1016/j.ejso.2014.11.040
12. Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol. 2020;54(2):237-46. DOI:10.2478/raon-2020-0016
13. Lyadov VK, Dikova TS, Zatsepina AYu, Ivashchenko DV. Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: sistematic review. Journal of Modern Oncology. 2022;24(2):234-41 (in Russian). DOI:10.26442/18151434.2022.2.201710
14. Qian J, Si Y, Zhou K, et al. Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy. BMC Gastroenterol. 2022;22(1):211. DOI:10.1186/s12876-022-02296-9
15. Ivanova AS, Obukhova OA, Kurmukov IA, Volf LY. Review of ESPEN-2021 Practice Guidelines for Cancer Patients: Part 1. Clinical Nutrition and Metabolism. 2022;3(3):140-52 (in Russian). DOI:10.17816/clinutr111900
16. Cederholm T, Jensen G, Correia MI, et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10(1):207-17. DOI:10.1002/jcsm.12383
17. Hersberger L, Bargetzi L, Bargetzi A, et al. Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short-term and long-term clinical outcomes: secondary analysis of a prospective randomised trial. Clin Nutr. 2020;39(9):2720-9. DOI:10.1016/j.clnu.2019.11.041
18. Sytov AV, Zuzov SA, Kukosh MYu, et al. Practical recommendations for nutritional support of cancer patients. Malignant Tumors. 2022;12(3S2-2):123-33 (in Russian). DOI:10.18027/2224-5057-2022-12-3s2-123-133
19. Kemper M, Molwitz I, Krause L, et al. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer? Clin Nutr. 2021;40(6):3729-40. DOI:10.1016/j.clnu.2021.04.040
20. Barcellos PS, Borges N, Torres DPM. Resting energy expenditure in cancer patients: Agreement between predictive equations and indirect calorimetry. Clin Nutr ESPEN.
2021;42:286-91. DOI:10.1016/j.clnesp.2021.01.019
21. Souza MTP, Singer P, Ozorio GA, et al. Resting energy expenditure and body composition in patients with head and neck cancer: An observational study leading to a new predictive equation. Nutrition. 2018;51-52:60-5. DOI:10.1016/j.nut.2017.12.006
22. Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021:40(5):2898-913. DOI:10.1016/j.clnu.2021.02.005
23. Cao DX, Wu GH, Zhang B, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr. 2010;29(1):72-7. 
DOI:10.1016/j.clnu.2009.07.001
24. Movahed S, Norouzy A, Ghanbari-Motlagh A, et al. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev. 2020;21(8):2315-23. DOI:10.31557/APJCP.2020.21.8.2315
25. Pham Van B, Nguyen Thi Thanh H, Le Thi H, et al. Nutritional Status and Feeding Regimen of Patients with Esophagus Cancer – A Study from Vietnam. Healthcare (Basel). 2021;9(3):289. DOI:10.3390/healthcare9030289
26. Cao Y, Han D, Zhou X, et al. Effects of preoperative nutrition on postoperative outcomes in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2022;35(3):doab028. DOI:10.1093/dote/doab028
27. Ravasco P, Monteiro Grillo I, Marques Vidal P, Camilo M. Nutritional counselling vs supplements: A prospective randomised controlled trial in head-neck cancer patients undergoing radiotherapy. Clin Nutr. 2003;22(Suppl. 1):S63-4. DOI:10.1016/s0261-5614(03)80236-4 
28. Obukhova OA, Bagrova SG, Besova NS, et al. The influence of additional enteral nutrition with a high content of protein and ω-3 fatty acids on the nutritional status and functional state during chemotherapy in patients with gastric cancer. Nutrition Issues. 2018;87(S5):106-7 (in Russian). DOI:10.24411/0042-8833-2018-10200 
29. Martin L, Findlay M, Bauer JD, et al. A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer: Results from INFORM. Nutrients. 2022;14(24):5272. DOI:10.3390/nu14245272
30. De Haan JJ, Moshage Y, Renken RJ, et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer. 2021;29(10):5691-9. DOI:10.1007/s00520-021-06049-4
31. Spiridonov VK, Tolochko ZS. Capsacin-sensory nerves and oxidative stress. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences. 2010;30(4):76-81 (in Russian). 
32. Liu B, Fan L, Balakrishna S, et al. TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain. 2013;154(10):2169-77. DOI:10.1016/j.pain.2013.06.043
33. Obukhova OA, Kashiya ShR, Kurmukov IA, et al. The use of additional oral nutrition during anticancer chemotherapy. A prospective randomized controlled trial. Intensive Care Bulletin. 2009;3:47-52 (in Russian). 
34. Kubota K, Kuroda J, Yoshida M, et al. Preoperative oral supplementation support in patients with esophageal cancer. J Nutr Health Aging. 2014;18(4):437-40.
DOI:10.1007/s12603-014-0018-2
35. Shen Y, Zhou Y, He T, Zhuang X. Effect of preoperative nutritional risk screening and enteral nutrition support in accelerated recovery after resection for esophageal cancer. Nutr Cancer. 2021;73(4):596-601. DOI:10.1080/01635581.2020.1764981
36. Faber J, Uitdehaag MJ, Spaander M, et al. Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction. J Cachexia Sarcopenia Muscle. 2015;6(1):32-44. DOI:10.1002/jcsm.12009
37. Low DE, Allum W, De Manzoni G, et al. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations. World J Surg. 2019;43(2):299-330. DOI:10.1007/s00268-018-4786-4 
38. Obukhova OA, Kashiya ShR, Kurmukov IA, Saltanov IA. Hyperglycemia of critical conditions. Emergency Medicine. 2011;4(35) (in Russian).
39. Liao M, Xia Z, Huang P, et al. Early enteral feeding on esophageal cancer patients after esophageal resection and reconstruction. Ann Palliat Med. 2020;9(3):816‑23. DOI:10.21037/apm.2020.04.13
40. Ivanova AS, Obukhova OA, Kurmukov IA, VolfLYa. Review of ESPEN-2021 Practice Guidelines for Patients with Cancer. Part 2: Interventions Relevant to Specific Patient Categories. Clinical Nutrition and Metabolism. 2022;3(4):193-206 (in Russian). DOI:10.17816/clinutr119059
41. Deftereos I, Yeung JMC, Arslan J, et al. Adherence to ESPEN guidelines and associations with postoperative outcomes in upper gastrointestinal cancer resection: results from the multi-centre NOURISH point prevalence study. Clin Nut ESPEN. 2021;47:391-8. DOI:10.1016/j.clnesp.2021.10.019
42. Constansia RDN, Hentzen JEKR, Hogenbirk RNM, et al. Actual postoperative protein and calorie intake in patients undergoing major open abdominal cancer surgery: A prospective, observational cohort study. Nutr Clin Pract. 2022;37(1):183-91. DOI:10.1002/ncp.10678
43. Papier I, Sagi-Dain L, Chermesh I, et al. Absence of oral nutritional support in low food intake inpatients is associated with an increased risk of hospital-acquired pressure injury. Clin Nutr ESPEN. 2022;51:190-8. DOI:10.1016/j.clnesp.2022.09.003
44. Liu L, Wang YC, Liu QW, et al. Home enteral nutrition after esophagectomy for esophageal cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2020;99(36):e21988. DOI:10.1097/MD.0000000000021988

О.А. Обухова*, И.А. Курмуков, О.Б. Абу-Хайдар

ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России, Москва, Россия
*obukhova0404@yandex.ru

________________________________________________

Olga A. Obukhova*, Ildar A. Kurmukov, Omar B. Abouhaidar

Blokhin National Medical Research Center of Oncology, Moscow, Russia
*obukhova0404@yandex.ru